BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bedair HS, Schurko BM, Dwyer MK, Novikov D, Anoushiravani AA, Schwarzkopf R. Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint Infection. J Arthroplasty 2019;34:132-5. [PMID: 30337253 DOI: 10.1016/j.arth.2018.09.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei W, Liu T, Zhao J, Li B, Li S, Liu J. Does the hepatitis C virus affect the outcomes of total joint arthroplasty? A meta-analysis of ten studies. J Orthop Sci 2019;24:822-9. [PMID: 30686688 DOI: 10.1016/j.jos.2018.12.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Li M, Glassman A. What’s New in Hip Replacement. The Journal of Bone and Joint Surgery 2019;101:1619-27. [DOI: 10.2106/jbjs.19.00553] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Cornell E, Novikov D, Niu R, Staatz K, Schwarzkopf R, Smith EL. Hepatitis C Antiviral Treatment Decreases All-Cause Complications After Total Joint Arthroplasty Regardless of the Presence of Fibrosis. J Arthroplasty 2021;36:1551-5. [PMID: 33431189 DOI: 10.1016/j.arth.2020.12.025] [Reference Citation Analysis]
4 Cheng T, Yang C, Hao L, Cheng X, Hu J, Ren W, Zhang X. Hepatitis C virus infection increases the risk of adverse outcomes following joint arthroplasty: A meta-analysis of observational studies. Orthop Traumatol Surg Res 2021;:102947. [PMID: 33930585 DOI: 10.1016/j.otsr.2021.102947] [Reference Citation Analysis]
5 Ross AJ, Ross BJ, Lee OC, Hood HW, Sanchez FL, Sherman WF. Does Preoperative Antiviral Treatment for Hepatitis C Decrease Risk of Complications After Total Hip Arthroplasty? A Matched Cohort Study. J Arthroplasty 2022:S0883-5403(22)00253-4. [PMID: 35248753 DOI: 10.1016/j.arth.2022.02.102] [Reference Citation Analysis]
6 Prentice HA, Chan PH, Royse KE, Hinman AD, Reddy NC, Paxton EW. Revision Risk in a Cohort of US Patients Younger Than 55 Undergoing Primary Elective Total Hip Arthroplasty. J Arthroplasty 2021:S0883-5403(21)00819-6. [PMID: 34718107 DOI: 10.1016/j.arth.2021.10.014] [Reference Citation Analysis]
7 Cheng T, Xu D, Yan Z, Ding C, Yang C, Zhang X. Antiviral Treatment for Hepatitis C Is Associated with a Reduced Risk of Periprosthetic Joint Infection: A Meta-analysis of Observational Studies. J Arthroplasty 2022:S0883-5403(22)00476-4. [PMID: 35483609 DOI: 10.1016/j.arth.2022.04.027] [Reference Citation Analysis]
8 Donnally CJ 3rd, Patel PD, Canseco JA, Shenoy K, Divi SN, Goz V, Arain AR, Vaccaro AR. Hepatitis C Virus Infection as a Predictor of Complications and Increased Costs Following Primary Lumbar Fusion Surgery. Spine (Phila Pa 1976) 2020;45:E1020-5. [PMID: 32706565 DOI: 10.1097/BRS.0000000000003481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Novikov D, Feng JE, Anoushiravani AA, Vigdorchik JM, Lajam CM, Seyler TM, Schwarzkopf R. Undetectable Hepatitis C Viral Load Is Associated With Improved Outcomes Following Total Joint Arthroplasty. J Arthroplasty 2019;34:2890-7. [PMID: 31351854 DOI: 10.1016/j.arth.2019.06.058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Salomon B, Krause PC, Dasa V, Shi L, Jones D, Chapple AG. The Impact of Hepatitis C and Liver Disease on Risk of Complications After Total Hip and Knee Arthroplasty: Analysis of Administrative Data From Louisiana and Texas. Arthroplast Today 2021;7:200-7. [PMID: 33553550 DOI: 10.1016/j.artd.2020.12.016] [Reference Citation Analysis]
11 Wiznia DH, Morgan RC Jr, Gibson D. Movement is Life-Optimizing Patient Access to Total Joint Arthroplasty: HIV and Hepatitis C Disparities. J Am Acad Orthop Surg 2021. [PMID: 34723921 DOI: 10.5435/JAAOS-D-21-00427] [Reference Citation Analysis]
12 Ross PE, Young JR, O'Connor CM, Anoushiravani AA, DiCaprio MR. Perioperative Management of Hepatitis C in Patients Undergoing Total Joint Arthroplasty. JBJS Rev 2021;9. [PMID: 34757978 DOI: 10.2106/JBJS.RVW.20.00223] [Reference Citation Analysis]
13 Shapiro CBH, Cheung RC, Giori NJ. Prevalence of Hepatitis C Virus Infection in the Veteran Population Undergoing Total Joint Arthroplasty: An Update. J Arthroplasty 2021;36:467-70. [PMID: 32900563 DOI: 10.1016/j.arth.2020.08.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sundaram K, Yakubek GA, Piuzzi NS, Vargas J, Klika AK, Higuera CA, Murray TG. Total Joint Arthroplasty Outcomes in Patients With a Previously Failed Toxicology Screen: A Propensity Score-Matched Analysis. J Arthroplasty 2019;34:1909-13. [PMID: 31229372 DOI: 10.1016/j.arth.2019.05.002] [Reference Citation Analysis]
15 Lespasio M, Mont M, Guarino A. Identifying Risk Factors Associated With Postoperative Infection Following Elective Lower-Extremity Total Joint Arthroplasty. Perm J 2020;24:1-3. [PMID: 33482967 DOI: 10.7812/TPP/20.013] [Reference Citation Analysis]